Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Loïc Lebellec, Anne-Sophie Defachelles, Pierre-Yves Cren & Nicolas Penel. (2020) Maintenance therapy and drug holiday in sarcoma patients: systematic review. Acta Oncologica 59:9, pages 1084-1090.
Read now
Read now
Douglas J. Harrison, David S. Geller, Jonathan D. Gill, Valerae O. Lewis & Richard Gorlick. (2018) Current and future therapeutic approaches for osteosarcoma. Expert Review of Anticancer Therapy 18:1, pages 39-50.
Read now
Read now
Winston W Huh, Daniela Egas-Bejar & Peter M Anderson. (2012) New treatment options for nonmetastatic osteosarcoma: focus on mifamurtide in adolescents. Clinical Oncology in Adolescents and Young Adults 2, pages 1-6.
Read now
Read now
Anne-Marie Cleton-Jansen, Emilie P. Buddingh & Arjan C. Lankester. (2012) Immunotherapy. OncoImmunology 1:2, pages 255-257.
Read now
Read now
Claudia Maria Hattinger, Michela Pasello, Stefano Ferrari, Piero Picci & Massimo Serra. (2010) Emerging drugs for high-grade osteosarcoma. Expert Opinion on Emerging Drugs 15:4, pages 615-634.
Read now
Read now
Thor Alvegård, Kirsten Sundby Hall, Henrik Bauer & Anders Rydholm. (2009) The Scandinavian Sarcoma Group. Acta Orthopaedica 80:sup334, pages 1-104.
Read now
Read now
Herrick J Siegel & Joseph G Pressey. (2008) Current concepts on the surgical and medical management of osteosarcoma. Expert Review of Anticancer Therapy 8:8, pages 1257-1269.
Read now
Read now
Joseph G Sinkovics. (2007) Adult human sarcomas. I. Basic science. Expert Review of Anticancer Therapy 7:1, pages 31-56.
Read now
Read now
Articles from other publishers (59)
Roelof van Ewijk, Nikolas Herold, Fredrik Baecklund, Daniel Baumhoer, Kjetil Boye, Nathalie Gaspar, Semi B. Harrabi, Lianne M. Haveman, Stefanie Hecker-Nolting, Laura Hiemcke-Jiwa, Valentine Martin, Cristina Mata Fernández, Emanuela Palmerini, Michiel A.J. van de Sande, Sandra J. Strauss, Stefan S. Bielack & Leo Kager. (2023) European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma. EJC Paediatric Oncology 2, pages 100029.
Crossref
Crossref
Jeong A Park & Nai-Kong V. Cheung. (2023) Promise and Challenges of T Cell Immunotherapy for Osteosarcoma. International Journal of Molecular Sciences 24:15, pages 12520.
Crossref
Crossref
Agnes L. Sorteberg, Linnea Ek, Ingrid Lilienthal & Nikolas Herold. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
39
.
Christine Schwering, Maya Niethard, Georg Gosheger, Maria Anna Smolle, Frank Traub, Simon Adam, Marcel-Philipp Henrichs, Hans Roland Dürr, Jendrik Hardes, Per-Ulf Tunn, Andreas Leithner & Dimosthenis Andreou. (2022) Are Postoperative Infections in the First 12 Months after Wide Resection and Megaprosthetic Replacement Associated with the Survival of Osteosarcoma Patients? Results of a Multicenter Study. Cancers 14:11, pages 2682.
Crossref
Crossref
I. Richert & A. Dutour. 2022. Bone Cancer. Bone Cancer
189
203
.
Alannah Smrke, Yuen B. Tam, Peter M. Anderson, Robin L. Jones & Paul H. Huang. (2021) The perplexing role of immuno-oncology drugs in osteosarcoma. Journal of Bone Oncology 31, pages 100400.
Crossref
Crossref
Lauren N. Alfino, Kai C. Wilczewski-Shirai, Kathryn E. Cronise, Jonathan Coy, Kristina Glapa, E. J. Ehrhart, Joseph B. Charles, Dawn L. Duval & Daniel P. Regan. (2021) Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome. Veterinary Pathology 58:5, pages 981-993.
Crossref
Crossref
Allison Pribnow, Karin Straathof & Robbie G. Majzner. 2021. Sarcomas of Bone and Soft Tissues in Children and Adolescents. Sarcomas of Bone and Soft Tissues in Children and Adolescents
165
180
.
Jeong A. Park & Nai-Kong V. Cheung. (2020) GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Ingrid Lilienthal & Nikolas Herold. (2020) Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. International Journal of Molecular Sciences 21:18, pages 6885.
Crossref
Crossref
Yarne Klaver, Maud Rijnders, Astrid Oostvogels, Rebecca Wijers, Marcel Smid, Dirk Grünhagen, Kees Verhoef, Stefan Sleijfer, Cor Lamers & Reno Debets. (2020) Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes. Journal for ImmunoTherapy of Cancer 8:2, pages e000271.
Crossref
Crossref
Panagiotis Tsagozis, Jordi Gonzalez-Molina, Anna-Maria Georgoudaki, Kaisa Lehti, Joseph Carlson, Andreas Lundqvist, Felix Haglund & Monika Ehnman. 2020. Tumor Microenvironments in Organs. Tumor Microenvironments in Organs
319
348
.
Hillary G. Pratt, E. Markel Justin & Brock A. Lindsey. 2020. Current Advances in the Science of Osteosarcoma. Current Advances in the Science of Osteosarcoma
91
109
.
Mary Frances Wedekind, Nicholas L. Denton, Chun-Yu Chen & Timothy P. Cripe. (2018) Pediatric Cancer Immunotherapy: Opportunities and Challenges. Pediatric Drugs 20:5, pages 395-408.
Crossref
Crossref
Ana Sebio, Breelyn A Wilky, Vicki L Keedy & Robin L Jones. (2018) The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Future Oncology 14:12, pages 1197-1211.
Crossref
Crossref
Amanda J. Saraf, Joelle M. Fenger & Ryan D. Roberts. (2018) Osteosarcoma: Accelerating Progress Makes for a Hopeful Future. Frontiers in Oncology 8.
Crossref
Crossref
Douglas J. Harrison & Cindy L. Schwartz. (2017) Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. Current Treatment Options in Oncology 18:4.
Crossref
Crossref
Atik Shaikh, Fangfei Li, Min Li, Bing He, Xiaojuan He, Guofen Chen, Baosheng Guo, Defang Li, Feng Jiang, Lei Dang, Shaowei Zheng, Chao Liang, Jin Liu, Cheng Lu, Biao Liu, Jun Lu, Luyao Wang, Aiping Lu & Ge Zhang. (2016) Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma. International Journal of Molecular Sciences 17:4, pages 506.
Crossref
Crossref
Michael A. Morse. (2016) Immunotherapy for Resected Pulmonary Metastases. Thoracic Surgery Clinics 26:1, pages 69-78.
Crossref
Crossref
JIA WAN, XIANGHONG ZHANG, TANG LIU & XIANGSHENG ZHANG. (2016) Strategies and developments of immunotherapies in osteosarcoma. Oncology Letters 11:1, pages 511-520.
Crossref
Crossref
Ola Myklebost. (2015) Personalized cancer therapy for soft tissue sarcomas: progress and pitfalls. Personalized Medicine 12:6, pages 593-602.
Crossref
Crossref
Stefan S. BielackSigbjørn SmelandJeremy S. WhelanNeyssa MarinaGordana JovicJane M. HookMark D. KrailoMark GebhardtZsuzsanna PápaiJames MeyerHelen NadelR. Lor RandallClaudia DeffenbaughRajaram NagarajanBernadette BrennanG. Douglas LetsonLisa A. TeotAllen GoorinDaniel BaumhoerLeo KagerMathias WernerChing C. LauKirsten Sundby HallHans GelderblomPaul MeyersRichard GorlickReinhard WindhagerKnut HelmkeMikael ErikssonPeter M. HoogerbruggePaula SchombergPer-Ulf TunnThomas KühneHeribert JürgensHenk van den BergTom BöhlingSusan PictonMarleen RenardPeter ReichardtJoachim GerssTrude Butterfass-BahloulCarol MorrisPancras C.W. HogendoornBeatrice SeddonGabriele CalaminusMaria MichelagnoliCatharina DhoogeMatthew R. SydesMark Bernstein. (2015) Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of Clinical Oncology 33:20, pages 2279-2287.
Crossref
Crossref
Melissa Burgess & Hussein Tawbi. (2015) Immunotherapeutic Approaches to Sarcoma. Current Treatment Options in Oncology 16:6.
Crossref
Crossref
Takenori Uehara, Tomohiro Fujiwara, Ken Takeda, Toshiyuki Kunisada, Toshifumi Ozaki & Heiichiro Udono. (2015) Immunotherapy for Bone and Soft Tissue Sarcomas. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Ernest C. Borden. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
739
752.e7
.
Lisa M. Kopp & Emmanuel Katsanis. 2015. Cancer Immunology. Cancer Immunology
47
67
.
Ryan D. Roberts, Mary Frances Wedekind & Bhuvana A. Setty. 2015. Malignant Pediatric Bone Tumors - Treatment & Management. Malignant Pediatric Bone Tumors - Treatment & Management
83
107
.
S. P. D'Angelo, W. D. Tap, G. K. Schwartz & R. D. Carvajal. (2014) Sarcoma Immunotherapy: Past Approaches and Future Directions. Sarcoma 2014, pages 1-13.
Crossref
Crossref
Alessandra Longhi, Marcus Reif, Erminia Mariani & Stefano Ferrari. (2014) A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-9.
Crossref
Crossref
Jolieke G. van Oosterwijk, Jakob K. Anninga, Hans Gelderblom, Anne-Marie Cleton-Jansen & Judith V.M.G. Bovée. (2013) Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma. Hematology/Oncology Clinics of North America 27:5, pages 1021-1048.
Crossref
Crossref
Kosei Ando, Marie-Françoise Heymann, Verena Stresing, Kanji Mori, Françoise Rédini & Dominique Heymann. (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers 5:4, pages 591-616.
Crossref
Crossref
Takeshi UdagawaKenta NarumiNaoko GotoKouichirou AidaKoji SuzukiTakahiro OchiyaAtsushi MakimotoTeruhiko YoshidaTatsuya ChikaraishiKazunori Aoki. (2012) Syngeneic Hematopoietic Stem Cell Transplantation Enhances the Antitumor Immunity of Intratumoral Type I Interferon Gene Transfer for Sarcoma. Human Gene Therapy 23:2, pages 173-186.
Crossref
Crossref
Jyoti Bajpai & Norman Jaffe. (2012) Perspectives of the Role of Chemotherapy in the Management of Osteosarcoma. Journal of Cancer Therapy 03:06, pages 1191-1203.
Crossref
Crossref
Launce G. Gouw, Kevin B. Jones, Sunil Sharma & R. Lor Randall. (2011) Sarcoma Immunotherapy. Cancers 3:4, pages 4139-4150.
Crossref
Crossref
Jakob K. Anninga, Hans Gelderblom, Marta Fiocco, Judith R. Kroep, Antoni H.M. Taminiau, Pancras C.W. Hogendoorn & R. Maarten Egeler. (2011) Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?. European Journal of Cancer 47:16, pages 2431-2445.
Crossref
Crossref
R Grant Rowe & Rashmi Chugh. (2011) Clinical trials of systemic therapy in osteosarcoma and Ewing’s sarcoma: past, present and future. Clinical Investigation 1:10, pages 1421-1443.
Crossref
Crossref
Seth M. Pollack, Elizabeth T. Loggers, Eve T. Rodler, Cassian Yee & Robin L. Jones. (2011) Immune-Based Therapies for Sarcoma. Sarcoma 2011, pages 1-7.
Crossref
Crossref
Antonio Briccoli, Michele Rocca, Mariacristina Salone, Gaetano Antonio Guzzardella, Alba Balladelli & Gaetano Bacci. (2010) High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surgical Oncology 19:4, pages 193-199.
Crossref
Crossref
David Buchbinder, Gary Steinberg, Michael Linetsky & Jacqueline Casillas. (2010) Moyamoya in a Child Treated With Interferon for Recurrent Osteosarcoma. Journal of Pediatric Hematology/Oncology 32:6, pages 476-478.
Crossref
Crossref
Xiang-E. Long, Zhao-Hui Gong, Lin Pan, Zhi-Wei Zhong, Yan-Ping Le, Qiong Liu, Jun-Ming Guo & Jiu-Chang Zhong. (2010) Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells. BMB Reports 43:4, pages 291-296.
Crossref
Crossref
Jeremy Whelan, Daniel Patterson, Martha Perisoglou, Stefan Bielack, Neyssa Marina, Sigbjorn Smeland & Mark Bernstein. (2009) The role of interferons in the treatment of osteosarcoma. Pediatric Blood & Cancer 54:3, pages 350-354.
Crossref
Crossref
Hang T. Ta, Crispin R. Dass, Peter F. M. Choong & Dave E. Dunstan. (2009) Osteosarcoma treatment: state of the art. Cancer and Metastasis Reviews 28:1-2, pages 247-263.
Crossref
Crossref
Alessandra Longhi, Erminia Mariani & Jürgen J. Kuehn. (2009) A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients. European Journal of Integrative Medicine 1:1, pages 27-33.
Crossref
Crossref
Noah Federman, Nicholas Bernthal, Fritz C. Eilber & William D. Tap. (2009) The Multidisciplinary Management of Osteosarcoma. Current Treatment Options in Oncology 10:1-2, pages 82-93.
Crossref
Crossref
David M. Loeb. 2010. Pediatric and Adolescent Osteosarcoma. Pediatric and Adolescent Osteosarcoma
447
457
.
F Fagioli, E Biasin, O M Mereuta, M Muraro, R Luksch, S Ferrari, M Aglietta & E Madon. (2008) Poor prognosis osteosarcoma: new therapeutic approach. Bone Marrow Transplantation 41:S2, pages S131-S134.
Crossref
Crossref
Stefan S. Bielack, Dorothe Carrle, Jendrik Hardes, Andreas Schuck & Michael Paulussen. (2008) Bone Tumors in Adolescents and Young Adults. Current Treatment Options in Oncology 9:1, pages 67-80.
Crossref
Crossref
Ernest C. Borden, Robert H. Silverman & Ganes Sen. 2008. The Molecular Basis of Cancer. The Molecular Basis of Cancer
621
633
.
Ernest C. Borden, Ganes C. Sen, Gilles Uze, Robert H. Silverman, Richard M. Ransohoff, Graham R. Foster & George R. Stark. (2007) Interferons at age 50: past, current and future impact on biomedicine. Nature Reviews Drug Discovery 6:12, pages 975-990.
Crossref
Crossref
Henk van den Berg. (2007) Biology and treatment of malignant solid tumors in childhood. Update on Cancer Therapeutics 2:4, pages 177-191.
Crossref
Crossref
Hans Strander. (2007) Interferons and osteosarcoma. Cytokine & Growth Factor Reviews 18:5-6, pages 373-380.
Crossref
Crossref
L. M. Jeys, R. J. Grimer, S. R. Carter, R. M Tillman & A. Abudu. (2007) Post Operative Infection and Increased Survival in Osteosarcoma Patients: Are They Associated?. Annals of Surgical Oncology 14:10, pages 2887-2895.
Crossref
Crossref
Alfons Billiau. (2007) Interferons: The pathways of discovery. Journal of Clinical Virology 39:4, pages 241-265.
Crossref
Crossref
Stefano Ferrari & Emanuela Palmerini. (2007) Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Current Opinion in Oncology 19:4, pages 341-346.
Crossref
Crossref
Susumu Joyama, Norifumi Naka, Yoshitane Tsukamoto, Hideki Yoshikawa & Kazuyuki Itoh. (2006) Dendritic Cell Immunotherapy is Effective for Lung Metastasis from Murine Osteosarcoma. Clinical Orthopaedics & Related Research 453, pages 318-327.
Crossref
Crossref
Jeremy Whelan, Beatrice Seddon & Martha Perisoglou. (2006) Management of osteosarcoma. Current Treatment Options in Oncology 7:6, pages 444-455.
Crossref
Crossref
Alessandra Longhi, Costantino Errani, Massimiliano De Paolis, Mario Mercuri & Gaetano Bacci. (2006) Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treatment Reviews 32:6, pages 423-436.
Crossref
Crossref
Henrik C. Bauer. 2003. TNM Online. TNM Online.
D. Schoeler & P. Reichardt. (2006) Aktuelle Entwicklungen in der Chemotherapie des OsteosarkomsCurrent therapeutic developments in the chemotherapy of osteosarcoma. Der Onkologe 12:2, pages 128-136.
Crossref
Crossref